AAPG · Ascentage Pharma Group International
Market Cap
$1.61B
Shares
93.39M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$18.28
Open$17.92
Day$17.73–18.28
52W close$16.69–42.47
Avg vol 30d6K
Short int14K · 0.0% float · 2.9d
Short vol94%
Last earningsAug 20, 2026
DataJan 2025–Aug 2026
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 14.4 · calm
Equity put/call 0.62
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−23%
below
Price vs 50-day avg
+1%
above
RSI (14)
52
neutral
MACD trend
Positive
52-week position
6%
near low
Momentum
relative strength
1-month return
+1%
trailing
6-month return
−18%
trailing
YTD return
−30%
this year
Relative strength
−31%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $18 › 200d $24 — 200d above 50d
Institutional flow
Accumulating
+14% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -9.9% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
8 holders — mid 1-yr range
Squeeze score
44
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
59%
annualized · 1-yr
Max drawdown
−65%
past year
ATR
4.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−23%
Bearish
Price vs 50-day avg
+1%
Bullish
RSI (14)
52
Neutral
MACD trend
Positive
Bullish
52-week position
6%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $18 › 200d $24 — 200d above 50d
Institutional flow
Accumulating
+14% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -9.9% MoM · 2.9 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
8 holders — mid 1-yr range
Price context
position in its 52-week range
Range low $17
Now $18 · 6%
Range high $42
vs 200-day avg -23%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AAPG
this stock
Ascentage Pharma Group International
|
$1.61B | -30.4% | — | — | 0.0% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$137.30B | +19.5% | +46.2% | 31.6 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$81.77B | +2.9% | +20.8% | 19.7 | 2.3% |
|
ARGX
Argenx SE
|
$63.63B | +21.7% | — | — | 1.9% |
|
CSLLY
Csl Ltd
|
$59.23B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AAPG | +7.5% | +1.1% | -17.9% | +4.9% | -30.4% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | +7.0% | -1.9% | -31.3% | +1.9% | -43.2% |